Ovid Therapeutics Inc. (OVID) DCF Valuation

Ovid Therapeutics Inc. (OVID) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Ovid Therapeutics Inc. (OVID) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess the intrinsic value of Ovid Therapeutics Inc.? Our (OVID) DCF Calculator integrates real data with comprehensive customization features, allowing you to refine your projections and enhance your investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 12.6 208.4 1.5 .4 .3 .3 .2 .2 .1
Revenue Growth, % 0 0 1551.57 -99.28 -73.93 -18.3 -18.3 -18.3 -18.3 -18.3
EBITDA -60.2 -81.1 124.4 -52.8 -58.7 -.1 -.1 -.1 .0 .0
EBITDA, % 100 -642.96 59.7 -3512.73 -14989.52 -28.06 -28.06 -28.06 -28.06 -28.06
Depreciation .3 .3 .2 1.4 1.6 .2 .2 .1 .1 .1
Depreciation, % 100 2.43 0.11373 91.94 407.61 58.9 58.9 58.9 58.9 58.9
EBIT -60.5 -81.4 124.2 -54.2 -60.3 -.1 -.1 -.1 .0 .0
EBIT, % 100 -645.4 59.58 -3604.66 -15397.12 -28.08 -28.08 -28.08 -28.08 -28.08
Total Cash 76.7 72.0 187.8 129.0 105.8 .3 .3 .2 .2 .1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.1 .1 .0 .0 .0
Account Receivables, % 100 1.12 0 0 0
Inventories .0 .0 .0 .0 .0 .1 .1 .0 .0 .0
Inventories, % 100 0 0 0 0 20 20 20 20 20
Accounts Payable 3.3 5.4 7.1 2.0 3.7 .2 .2 .1 .1 .1
Accounts Payable, % 100 43.16 3.42 129.96 945.36 69.32 69.32 69.32 69.32 69.32
Capital Expenditure -.2 -.4 -.2 -1.4 -.1 -.1 -.1 -.1 .0 .0
Capital Expenditure, % 100 -3.1 -0.09089427 -94.41 -35.09 -26.54 -26.54 -26.54 -26.54 -26.54
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -59.3 -81.1 122.8 -51.4 -60.3 -.1 -.1 -.1 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -57.1 -78.0 124.7 -56.6 -57.1 -3.6 .0 .0 .0 .0
WACC, % 6 6.02 6.01 5.98 6.02 6 6 6 6 6
PV UFCF
SUM PV UFCF -3.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -3
Net Debt -11
Equity Value 8
Diluted Shares Outstanding, MM 71
Equity Value Per Share 0.11

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real OVID financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the highlighted cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effects of your inputs on Ovid Therapeutics' valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of navigation, complete with step-by-step instructions.

Key Features

  • Comprehensive Data: Ovid Therapeutics Inc.'s historical financial statements and pre-filled projections.
  • Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Results: Observe Ovid's intrinsic value recalculating instantly.
  • Visual Data Representation: Dashboard charts illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based OVID DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Ovid Therapeutics' intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Utilize the results to inform your investment or financial decisions.

Why Choose Ovid Therapeutics Inc. (OVID)?

  • Innovative Solutions: Focused on developing therapies for rare neurological diseases.
  • Scientific Expertise: Led by a team of experienced professionals in neuroscience and drug development.
  • Robust Pipeline: Diverse range of product candidates targeting unmet medical needs.
  • Strong Partnerships: Collaborations with leading academic institutions and biopharmaceutical companies.
  • Commitment to Patients: Dedicated to improving the lives of patients and their families.

Who Should Use This Product?

  • Investors: Accurately assess Ovid Therapeutics Inc.’s (OVID) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
  • Consultants: Efficiently modify the template for valuation reports tailored to clients.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms.
  • Educators: Implement it as a teaching resource to illustrate various valuation methodologies.

What the Template Contains

  • Preloaded OVID Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.